1. Bachurin S. O., Sablin S. O., Grishina G. V., Gaydarova E. L., Dubova L. G., and Zubov N. D. (1989a) Monoamine oxidase catalysis of bioconversion of physiologically active 1-methyl-4-aryl-1,2,3,6-tetrahydropyridines.Bioorganicheskaya khimia (Russ.) 15, 620–626.
2. Bachurin S. O., Solyakov L. S., Lermontova N. N., Tkachenko S. E., Kalashnikov V. V., Serkova T. P., and Petrova L. N. (1989b) The role of dopamine-uptake system in the development of experimental parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridine analogs.Doklady Acad. Nauk USSR (Russ.) 307, 740–743.
3. Bachurin S. O., Tkachenko S. E., and Lermontova N. N. (1991) Pyridine derivatives: structure-activity relationships causing parkinsonism-like symptoms.Rev. Environm. Contam. Toxicol. 122, 1–36.
4. Chiba K., Trevor A. J., and Castagnoli n. (1985) Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.Biochem. Biophys. Res. Commun. 128, 1228–1232.
5. Dixon M. and Webb E. C. (1964)Enzymes. pp. 84–87, Longmans, London, New York.